New insights on the phytochemical intervention for the treatment of neuropsychiatric disorders using the leaves of Michelia champaca: an in vivo and in silico approach

Context Michelia champaca L. (Magnoliaceae) has been known since ancient times for its rich medicinal properties.Objective The ethanol extract of Michelia champaca leaves (EEMC) was evaluated on depression and anxiety using in vivo and in silico studiesMaterials and methods Swiss albino mice were di...

Full description

Bibliographic Details
Main Authors: Pushpa V. H., Jayanthi M. K., Rashmi H. R., Veeresh Kumar N. Shivamurthy, Shashank M. Patil, Prithvi S. Shirahatti, Ramith Ramu
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Pharmaceutical Biology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/13880209.2022.2101669
_version_ 1811299435666210816
author Pushpa V. H.
Jayanthi M. K.
Rashmi H. R.
Veeresh Kumar N. Shivamurthy
Shashank M. Patil
Prithvi S. Shirahatti
Ramith Ramu
author_facet Pushpa V. H.
Jayanthi M. K.
Rashmi H. R.
Veeresh Kumar N. Shivamurthy
Shashank M. Patil
Prithvi S. Shirahatti
Ramith Ramu
author_sort Pushpa V. H.
collection DOAJ
description Context Michelia champaca L. (Magnoliaceae) has been known since ancient times for its rich medicinal properties.Objective The ethanol extract of Michelia champaca leaves (EEMC) was evaluated on depression and anxiety using in vivo and in silico studiesMaterials and methods Swiss albino mice were divided into control, standard, 100 and 200 mg/kg b.w. EEMC groups and for drug administration using oral gavage. The antidepressant activity was evaluated using forced swim test (FST) and tail suspension test (TST) whereas the anxiolytic activity through elevated plus maze and light and dark tests. The in silico studies included molecular docking against human potassium channel KCSA-FAB and human serotonin transporter, and ADME/T analysis.Results Open arm duration and entries were comparable between 200 mg/kg b.w. group (184.45 ± 1.00 s and 6.25 ± 1.11, respectively) and that of diazepam treated group (180.02 s ± 0.40 and 6.10 ± 0.05, respectively). Time spent in the light cubicle was higher (46.86 ± 0.03%), similar to that of diazepam (44.33 ± 0.64%), suggesting its potent anxiolytic activity. A delayed onset of immobility and lowered immobility time was seen at both the treatment doses (FST: 93.7 ± 1.70 and 89.1 ± 0.40 s; TST: 35.05 ± 2.75 and 38.50 ± 4.10 s) and the standard drug imipramine (FST: 72.7 ± 3.72 and TST: 30.01 ± 2.99 s), indicative of its antidepressant ability. In silico studies predicted doripenem to induce anxiolytic and antidepressant activity by inhibiting human potassium channel KCSA-FAB and human serotonin transporter proteins, respectively.Conclusions EEMC is a rich source of bioactive compounds with strong antidepressant and anxiolytic properties.
first_indexed 2024-04-13T06:35:55Z
format Article
id doaj.art-c1a8013d5b224a459997e7119b30caa1
institution Directory Open Access Journal
issn 1388-0209
1744-5116
language English
last_indexed 2024-04-13T06:35:55Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Pharmaceutical Biology
spelling doaj.art-c1a8013d5b224a459997e7119b30caa12022-12-22T02:57:56ZengTaylor & Francis GroupPharmaceutical Biology1388-02091744-51162022-12-016011656166810.1080/13880209.2022.2101669New insights on the phytochemical intervention for the treatment of neuropsychiatric disorders using the leaves of Michelia champaca: an in vivo and in silico approachPushpa V. H.0Jayanthi M. K.1Rashmi H. R.2Veeresh Kumar N. Shivamurthy3Shashank M. Patil4Prithvi S. Shirahatti5Ramith Ramu6Department of Pharmacology, JSS Medical College, JSS Academy of Higher Education and Research, Mysuru, IndiaDepartment of Pharmacology, JSS Medical College, JSS Academy of Higher Education and Research, Mysuru, IndiaDepartment of Pharmacology, JSS Medical College, JSS Academy of Higher Education and Research, Mysuru, IndiaDepartment of Neurology, Saint Francis Hospital and Medical Center, Trinity Health Of New England, Hartford, CT, USADepartment of Biotechnology and Bioinformatics, JSS Academy of Higher Education and Research, Mysuru, IndiaDepartment of Biotechnology, Teresian College, Mysuru, IndiaDepartment of Biotechnology and Bioinformatics, JSS Academy of Higher Education and Research, Mysuru, IndiaContext Michelia champaca L. (Magnoliaceae) has been known since ancient times for its rich medicinal properties.Objective The ethanol extract of Michelia champaca leaves (EEMC) was evaluated on depression and anxiety using in vivo and in silico studiesMaterials and methods Swiss albino mice were divided into control, standard, 100 and 200 mg/kg b.w. EEMC groups and for drug administration using oral gavage. The antidepressant activity was evaluated using forced swim test (FST) and tail suspension test (TST) whereas the anxiolytic activity through elevated plus maze and light and dark tests. The in silico studies included molecular docking against human potassium channel KCSA-FAB and human serotonin transporter, and ADME/T analysis.Results Open arm duration and entries were comparable between 200 mg/kg b.w. group (184.45 ± 1.00 s and 6.25 ± 1.11, respectively) and that of diazepam treated group (180.02 s ± 0.40 and 6.10 ± 0.05, respectively). Time spent in the light cubicle was higher (46.86 ± 0.03%), similar to that of diazepam (44.33 ± 0.64%), suggesting its potent anxiolytic activity. A delayed onset of immobility and lowered immobility time was seen at both the treatment doses (FST: 93.7 ± 1.70 and 89.1 ± 0.40 s; TST: 35.05 ± 2.75 and 38.50 ± 4.10 s) and the standard drug imipramine (FST: 72.7 ± 3.72 and TST: 30.01 ± 2.99 s), indicative of its antidepressant ability. In silico studies predicted doripenem to induce anxiolytic and antidepressant activity by inhibiting human potassium channel KCSA-FAB and human serotonin transporter proteins, respectively.Conclusions EEMC is a rich source of bioactive compounds with strong antidepressant and anxiolytic properties.https://www.tandfonline.com/doi/10.1080/13880209.2022.2101669Antidepressant activityanxiolytic activityMagnoliaceae familyforced swim testtail suspension testmolecular docking studies
spellingShingle Pushpa V. H.
Jayanthi M. K.
Rashmi H. R.
Veeresh Kumar N. Shivamurthy
Shashank M. Patil
Prithvi S. Shirahatti
Ramith Ramu
New insights on the phytochemical intervention for the treatment of neuropsychiatric disorders using the leaves of Michelia champaca: an in vivo and in silico approach
Pharmaceutical Biology
Antidepressant activity
anxiolytic activity
Magnoliaceae family
forced swim test
tail suspension test
molecular docking studies
title New insights on the phytochemical intervention for the treatment of neuropsychiatric disorders using the leaves of Michelia champaca: an in vivo and in silico approach
title_full New insights on the phytochemical intervention for the treatment of neuropsychiatric disorders using the leaves of Michelia champaca: an in vivo and in silico approach
title_fullStr New insights on the phytochemical intervention for the treatment of neuropsychiatric disorders using the leaves of Michelia champaca: an in vivo and in silico approach
title_full_unstemmed New insights on the phytochemical intervention for the treatment of neuropsychiatric disorders using the leaves of Michelia champaca: an in vivo and in silico approach
title_short New insights on the phytochemical intervention for the treatment of neuropsychiatric disorders using the leaves of Michelia champaca: an in vivo and in silico approach
title_sort new insights on the phytochemical intervention for the treatment of neuropsychiatric disorders using the leaves of michelia champaca an in vivo and in silico approach
topic Antidepressant activity
anxiolytic activity
Magnoliaceae family
forced swim test
tail suspension test
molecular docking studies
url https://www.tandfonline.com/doi/10.1080/13880209.2022.2101669
work_keys_str_mv AT pushpavh newinsightsonthephytochemicalinterventionforthetreatmentofneuropsychiatricdisordersusingtheleavesofmicheliachampacaaninvivoandinsilicoapproach
AT jayanthimk newinsightsonthephytochemicalinterventionforthetreatmentofneuropsychiatricdisordersusingtheleavesofmicheliachampacaaninvivoandinsilicoapproach
AT rashmihr newinsightsonthephytochemicalinterventionforthetreatmentofneuropsychiatricdisordersusingtheleavesofmicheliachampacaaninvivoandinsilicoapproach
AT veereshkumarnshivamurthy newinsightsonthephytochemicalinterventionforthetreatmentofneuropsychiatricdisordersusingtheleavesofmicheliachampacaaninvivoandinsilicoapproach
AT shashankmpatil newinsightsonthephytochemicalinterventionforthetreatmentofneuropsychiatricdisordersusingtheleavesofmicheliachampacaaninvivoandinsilicoapproach
AT prithvisshirahatti newinsightsonthephytochemicalinterventionforthetreatmentofneuropsychiatricdisordersusingtheleavesofmicheliachampacaaninvivoandinsilicoapproach
AT ramithramu newinsightsonthephytochemicalinterventionforthetreatmentofneuropsychiatricdisordersusingtheleavesofmicheliachampacaaninvivoandinsilicoapproach